HK1042301A1 - Semi-synthesis of paclitaxel using dialkyldichlorosilanes - Google Patents

Semi-synthesis of paclitaxel using dialkyldichlorosilanes

Info

Publication number
HK1042301A1
HK1042301A1 HK02104142A HK02104142A HK1042301A1 HK 1042301 A1 HK1042301 A1 HK 1042301A1 HK 02104142 A HK02104142 A HK 02104142A HK 02104142 A HK02104142 A HK 02104142A HK 1042301 A1 HK1042301 A1 HK 1042301A1
Authority
HK
Hong Kong
Prior art keywords
paclitaxel
synthesis
dialkyldichlorosilanes
semi
dialkylalkoxysilyl
Prior art date
Application number
HK02104142A
Other languages
English (en)
Inventor
Purushotham Vemishetti
Francis S Gibson
John L Dillon Jr
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of HK1042301A1 publication Critical patent/HK1042301A1/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D305/00Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms
    • C07D305/14Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms condensed with carbocyclic rings or ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/337Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02Silicon compounds
    • C07F7/08Compounds having one or more C—Si linkages
    • C07F7/18Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Epoxy Compounds (AREA)
  • Silicon Polymers (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Paper (AREA)
HK02104142A 1999-05-28 2002-05-31 Semi-synthesis of paclitaxel using dialkyldichlorosilanes HK1042301A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US13655999P 1999-05-28 1999-05-28
PCT/US2000/013639 WO2000073293A1 (en) 1999-05-28 2000-05-18 Semi-synthesis of paclitaxel using dialkyldichlorosilanes

Publications (1)

Publication Number Publication Date
HK1042301A1 true HK1042301A1 (en) 2002-08-09

Family

ID=22473365

Family Applications (1)

Application Number Title Priority Date Filing Date
HK02104142A HK1042301A1 (en) 1999-05-28 2002-05-31 Semi-synthesis of paclitaxel using dialkyldichlorosilanes

Country Status (18)

Country Link
US (1) US6242614B1 (xx)
EP (1) EP1183250B1 (xx)
JP (1) JP2003502290A (xx)
KR (1) KR100603877B1 (xx)
AT (1) ATE342260T1 (xx)
AU (1) AU776216B2 (xx)
CA (1) CA2375253A1 (xx)
CY (1) CY1105837T1 (xx)
DE (1) DE60031269T2 (xx)
DK (1) DK1183250T3 (xx)
ES (1) ES2273698T3 (xx)
HK (1) HK1042301A1 (xx)
HU (1) HUP0201266A3 (xx)
IL (1) IL145869A (xx)
MX (1) MXPA01012177A (xx)
PT (1) PT1183250E (xx)
TW (1) TW593300B (xx)
WO (1) WO2000073293A1 (xx)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ298333B6 (cs) * 2005-09-26 2007-08-29 Zentiva, A. S Zpusob prípravy 7-trialkylsilylbaccatinu III
GB0701523D0 (en) * 2007-01-26 2007-03-07 Chatham Biotec Ltd Semi-synthetic process for the preparation of taxane derivatives
WO2009023967A1 (en) * 2007-08-22 2009-02-26 6570763 Canada Inc. Process for converting 9-dihydro-13-acetylbaccatin iii into docetaxel or paclitaxel
WO2009137084A2 (en) * 2008-05-07 2009-11-12 Ivax Research, Llc Processes for preparation of taxanes and intermediates thereof
US8791279B2 (en) * 2010-12-13 2014-07-29 Yung Shin Pharm. Ind. Co., Ltd. Process for preparing taxoids from baccatin derivatives using lewis acid catalyst
US9375484B2 (en) * 2011-05-31 2016-06-28 Regents Of The University Of Minnesota Taxane silicate prodrugs and nanoparticles
KR101378537B1 (ko) * 2011-09-30 2014-03-28 주식회사 삼양바이오팜 10-디아세틸파클리탁셀로부터 파클리탁셀을 제조하는 방법
CN103145654A (zh) * 2013-04-12 2013-06-12 江苏斯威森生物医药工程研究中心有限公司 一种多西他赛的半合成方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE34277E (en) 1988-04-06 1993-06-08 Centre National De La Recherche Scientifique Process for preparing taxol
US5175315A (en) 1989-05-31 1992-12-29 Florida State University Method for preparation of taxol using β-lactam
US5243045A (en) 1991-09-23 1993-09-07 Florida State University Certain alkoxy substituted taxanes and pharmaceutical compositions containing them
US5274124A (en) 1991-09-23 1993-12-28 Florida State University Metal alkoxides
CA2418125C (en) 1991-09-23 2007-12-04 Florida State University Beta-lactams useful in the preparation of substituted isoserine esters
US5973160A (en) * 1992-12-23 1999-10-26 Poss; Michael A. Methods for the preparation of novel sidechain-bearing taxanes
EP0682660B1 (en) * 1993-02-05 2003-11-05 Bryn Mawr College Synthesis of taxol, analogs and intermediates with variable a-ring side chains
US6005120A (en) * 1993-07-20 1999-12-21 Florida State University Tricyclic and tetracyclic taxanes
JPH1192468A (ja) * 1997-09-17 1999-04-06 Yakult Honsha Co Ltd 新規なタキサン誘導体
US6150537A (en) * 1997-12-12 2000-11-21 Emory University Methods for the esterification of alcohols and compounds useful therefor as potential anticancer agents
US6156789A (en) * 1998-03-17 2000-12-05 Rhone-Poulenc Rorer S.A. Method for treating abnormal cell proliferation in the brain
US6136988A (en) * 1998-04-10 2000-10-24 Hauser, Inc. 7-hexanoyltaxol and methods for preparing the same
JP4502338B2 (ja) * 1999-09-17 2010-07-14 株式会社横浜国際バイオ研究所 タキソイド化合物の製造法

Also Published As

Publication number Publication date
HUP0201266A2 (en) 2002-08-28
JP2003502290A (ja) 2003-01-21
EP1183250A1 (en) 2002-03-06
IL145869A0 (en) 2002-07-25
HUP0201266A3 (en) 2005-02-28
AU776216B2 (en) 2004-09-02
CA2375253A1 (en) 2000-12-07
MXPA01012177A (es) 2002-07-22
DK1183250T3 (da) 2007-01-08
ATE342260T1 (de) 2006-11-15
EP1183250B1 (en) 2006-10-11
ES2273698T3 (es) 2007-05-16
DE60031269D1 (de) 2006-11-23
PT1183250E (pt) 2006-12-29
EP1183250A4 (en) 2002-11-13
KR20020032426A (ko) 2002-05-03
DE60031269T2 (de) 2007-05-31
US6242614B1 (en) 2001-06-05
AU5140800A (en) 2000-12-18
WO2000073293A1 (en) 2000-12-07
TW593300B (en) 2004-06-21
IL145869A (en) 2005-07-25
KR100603877B1 (ko) 2006-07-25
CY1105837T1 (el) 2011-02-02

Similar Documents

Publication Publication Date Title
PH31610A (en) Taxol derivatives.
HUP0100270A2 (hu) Eljárások és vegyületek béta-amiloid peptid kibocsátás és/vagy szintézisgátló peptidek, ezeket tartalmazó gyógyászati készítmények és alkalmazásuk
TW268942B (xx)
GB2346878A (en) Preparation of 3-substituted adenines
EP0592677A4 (en) -g(b)-lactam compound and cephem compound, and production thereof
GR3034542T3 (en) 4,5-diaryloxazole derivatives
BG106340A (en) Substituted oxoazaheterocyclyl compounds
MY132671A (en) Substituted 6,6-hetero-bicyclic derivatives
AU2328092A (en) Process for the preparation of baccatin iii and 10-deacetyl baccatin iii derivatives
HK1019878A1 (en) Total synthesis of antitumor acylfulvenes.
AU2178497A (en) Cephem compounds and drugs containing the compounds
CY1105837T1 (el) Hmi - συνθεση απο paclitaxel με χρησιμοποιηση διαλκυλδιχλωροσιλανιων
EP0700291A4 (en) 4-AZASTEROIDS SUBSTITUTED IN THE 15-POSITION
MX9805023A (es) Derivados de 1-metilcarbapenem.
IL108836A0 (en) C9 taxane derivatives and pharmaceutical compositions containing them
HUT67551A (en) New 17,20-epoxy-pregnane derivatives and their production
AP2001002314A0 (en) Substituted benzolactam compounds.
ZA9811380B (xx)
DE69830653D1 (en) Chelatisierungsmitteln
EP1197211A4 (en) CANCER PREVENTION AND TREATMENT ACTIVE INGREDIENTS
WO2000003681A3 (en) Process for the synthesis of benzopyran derivatives
IL131380A0 (en) The use of a compound for the manufacture of a pharmaceutical preparatin for the treatment or prevention of prostate cancer
AU2178199A (en) Azetidinecarboxamide derivatives for the treatment of cns disorders
AU7020996A (en) UCK14 compounds
AU2353595A (en) Antitumor indolopyprolocarbazole derivative

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20100518